financetom
Business
financetom
/
Business
/
US FDA warns Hims & Hers over misleading claims on diabetes, weight-loss drugs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA warns Hims & Hers over misleading claims on diabetes, weight-loss drugs
Sep 16, 2025 9:24 AM

Sept 16 (Reuters) - The U.S. Food and Drug

Administration has sent a warning letter to telehealth firm Hims

& Hers Health ( HIMS ) regarding its compounded versions of Novo

Nordisk's diabetes drug Ozempic and weight-loss

treatment Wegovy.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved